Starting highly active antiretroviral therapy: why, when and response to HAART.

Abstract

Highly active antiretroviral therapy (HAART) has dramatically improved the prognosis of patients with HIV, although it remains unclear as to the best time to start treatment to reduce the risk of clinical progression. The initial virological response to HAART, by reducing viral load to below the limit of detection, is essential for reducing the risk of drug… (More)

2 Figures and Tables

Topics

  • Presentations referencing similar topics